BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Learn the long-term average annual return for index funds and how it informs portfolio construction, diversification, and risk management.
27,739 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Wells Fargo lowers Amazon's price target to $312 while keeping an Overweight rating, highlighting AWS as the core eng...
ETH dips below the $2,000 mark as global risk-off sentiment intensifies. Analysts warn the pullback could extend unle...
Biotech investing hinges on milestones and discipline. This article breaks down inmune (INMB) 2025 earnings, what the...
Investors are watching Nomad Foods navigate a tough year. While the stock has fallen, there are hidden strengths and ...
Broadcom is trading around $315, down about 9% year-to-date, as analysts push a $454 12-month target on accelerating ...
India tightened gold import rules this week, a move officials say protects the rupee, but traders warn it could bolst...
Duolingo's stock sank after the company sacrificed $50 million in bookings to speed up user growth, aiming for 100 mi...
A quiet, strategic move by Warren Buffett's Berkshire Hathaway placed a small bet on The New York Times. Here’s what ...
In May, nano nuclear energy powered stocks surged as collaborations with data centers and regulatory progress lifted ...
The ADA conference spotlighted Lilly and Novo Nordisk in the GLP-1 race. This deep dive explains what the claims mean...
X-Energy stock faced a sharp 19.2% drop this week after project delays and a downgrade. This article breaks down the ...